Epidemiology and survival of cutaneous melanoma in Spain: A report of 552 cases (1994-2003);Epidemiología y supervivencia del melanoma cutáneo en España: Estudio de 552 casos (1994-2003)

Revista Clinica Espanola

Volumn 206, Issue 7, 2006, Pages 319-325

  Aviles Izquierdo J A ^a   Lazaro P ^a   Lecona, M ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Cutaneous melanoma; Epidemiology; Survival

Indexed keywords

ADULT; ADVANCED CANCER; AGE; AGED; ARTICLE; CANCER CENTER; CANCER INCIDENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; EPIDEMIOLOGICAL DATA; FEMALE; GENDER; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; SKIN ULCER; SPAIN; THICKNESS;

EID: 33746877485     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: 10.1157/13090479     Document Type: Article

References (41)

1. MacLennan R, Green AC, McLeod GR, Martin NG. Increasing incidence of cutaneous melanoma in Queensland, Australia. J Natl Cancer Inst. 1992;84:1427-32.
2. Lázaro Ochaita P, Suárez Fernández R, Avilés Izquierdo JA. Epidemiología del melanoma cutáneo. Clínicas Dermatológicas de la AEDV; 2003.
3. Tanaka H, Tsukuma H, Tomita S, et al. Time trends of incidence for cutaneous melanoma among the Japanese population: an analysis of Osaka Cancer Registry data 1964-95. J Epidemiol. 1999;9:S129-S35.
4. Vinceti M, Bergomi M, Borciani N, Serra L, Vivoli G. Rising melanoma incidence in an Italian community from 1986 to 1997. Melanoma Res. 1999;9:97-103.
5. Soon SL, Solomon AR, Papadopoulos D, et al. Acral lentiginous melanoma mimicking benign disease: the emory experience. J Am Acad Dermatol. 2003;48:183-8.
6. Diepgen TL, Mahler V. The epidemiology of skin cancer. Br J Dermatol. 2002;146 Suppl 61:1-6.
7. Bevona C, Sober AJ. Melanoma incidence trends. Dermatol Clin. 2002; 20:589-95, vii.
8. Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol. 2001;19:3635-48.
9. Weinstock MA. Issues in the epidemiology of melanoma. Hematol Oncol Clin North Am. 1998;12:681-98.
10. Garbe C, McLeod GR, Buettner PG. Time trends of cutaneous melanoma in Queensland, Australia and Central Europe. Cancer. 2000; 89:1269-78.
11. Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1998;83: 1664-78.
12. Sturm RA. Skin colour and skin cancer - MC1R, the genetic link. Melanoma Res. 2002;12:405-16.
13. Rodríguez Blas MC VÁF. Cáncer de piel. Ministerio de Sanidad y Consumo, Subdirección General de Epidemiología, Promoción y Educación para la Salud. Madrid. 1999.
14. Ocaña-Riola R, Martínez-García C, Serrano S, Buendía-Eisman A, Ruiz-Baena C, Canela-Soler J. Population-based study of cutaneous malignant melanoma in the Granada province (Spain), 1985-1992. Eur J Epidemiol. 2001;17:169-74.
15. Serrano S. Incidencia de melanoma en España. Registro Nacional de Melanomas. Santander: Libro de Resúmenes XXVII Congreso Nacional de Dermatología y Venereología; 1998. p. 32-3.
16. Academia Española de Dermatología y Venereología A. Registro Nacional de Melanoma. Año 2003. Madrid. Disponible en: www.aedv.es
17. Burton RC, Armstrong BK. Current melanoma epidemic: a nonmetastasizing form of melanoma? World J Surg. 1995;19:330-3.
18. Rees JL. The melanoma epidemic: reality and artefact. Bmj. 1996; 312:137-8.
19. Swerlick RA, Chen S. The melanoma epidemic: more apparent than real? Mayo Clin Proc. 1997;72:559-64.
20. Horn-Ross PL, Holly EA, Brown SR, Aston DA. Temporal trends in the incidence of cutaneous malignant melanoma among Caucasians in the San Francisco-Oakland MSA. Cancer Causes Control. 1991;2:299-305.
21. Van der Esch EP, Muir CS, Nectoux J, Macfarlane G, Maisonneuve P, Bharucha H, et al. Temporal change in diagnostic criteria as a cause of the increase of malignant melanoma over time is unlikely. Int J Cancer. 1991; 47:483-9.
22. Dennis LK. Analysis of the melanoma epidemic, both apparent and real: data from the 1973 through 1994 surveillance, epidemiology, and end results program registry. Arch Dermatol. 1999;135:275-80.
23. Sim FH, Nelson TE, Pritchard DJ. Malignant melanoma: Mayo Clinic experience. Mayo Clin Proc. 1997;72:565-9.
24. Lens MB, Dawes M. Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol. 2004; 150:179-85.
25. Giles GG, Armstrong BK, Burton RC, Staples MP, Thursfield VJ. Has mortality from melanoma stopped rising in Australia? Analysis of trends between 1931 and 1994. Bmj. 1996;312:1121-5.
26. La Vecchia C, Lucchini F, Negri E, Levi F. Recent declines in worldwide mortality from cutaneous melanoma in youth and middle age. Int J Cancer. 1999;81:62-6.
27. Balzi D, Carli P, Giannotti B, Paci E, Buiatti E. Cutaneous melanoma in the Florentine area, Italy: incidence, survival and mortality between 1985 and 1994. Eur J Cancer Prev. 2003;12:43-8.
28. Jemal A, Devesa SS, Fears TR, Hartge P. Cancer surveillance series: changing patterns of cutaneous malignant melanoma mortality rates among whites in the United States. J Natl Cancer Inst. 2000;92:811-8.
29. Kolmel KF, Kulle B, Lippold A, Seebacher C. Survival probabilities and hazard functions of malignant melanoma in Germany 1972-1996, an analysis of 10433 patients. Evolution of gender differences and malignancy. Eur J Cancer. 2002;38:1388-94.
30. Edwards BK, Howe HL, Ries LA, Thun MJ, Rosenberg HM, Yancik R, et al. Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden. Cancer. 2002; 94:2766-92.
31. Coleman MP, Esteve J, Damiecki P, Arslan A, Renard H. Trends in cancer incidence and mortality. IARC Sci Publ; 1993. p. 1-806.
32. González Arraez JI CVC, Alfonso Sánchez JL, Jiménez Fernández FJ, Gil Mary A. Melanoma maligno de piel: Estudio de la mortalidad y principales factores de riesgo. España 1951-1983. Actas Dermo-Sif. 1989;80:33-9.
33. Nieto A, Ruiz-Ramos M, Abdel-Kader L, Conde M, Camacho F. Gender differences in rising trends in cutaneous malignant melanoma in Spain, 1975-98. Br J Dermatol. 2003;148:110-6.
34. Ries LA, Wingo PA, Miller DS, Howe HL, Weir HK, Rosenberg HM, et al. The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer. 2000;88:2398-424.
35. MacKie RM, Hole D, Hunter JA, Rankin R, Evans A, McLaren K, et al. Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94. The Scottish Melanoma Group. Bmj. 1997;315:1117-21.
36. Marks R. The changing incidence and mortality of melanoma in Australia. Recent Results Cancer Res. 2002;160:113-21.
37. MacKie RM, Bray CA, Leman JA. Effect of public education aimed at early diagnosis of malignant melanoma: cohort comparison study. Bmj. 2003;326:367.
38. Swerlick RA, Chen S. The melanoma epidemic. Is increased surveillance the solution or the problem? Arch Dermatol. 1996;132:881-4.
39. Rigel DS. Malignant melanoma: incidence issues and their effect on diagnosis and treatment in the 1990s. Mayo Clin Proc. 1997;72:367-71.
40. Balzi D, Carli P, Giannotti B, Buiatti E. Skin melanoma in Italy: a population-based study on survival and prognostic factors. Eur J Cancer. 1998;34:699-704.
41. Levi F, Randimbison L, La Vecchia C, Te VC, Franceschi S. Prognostic factors for cutaneous malignant melanoma in Vaud, Switzerland. Int J Cancer. 1998;78:315-9.